|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C67.3 |
Malignant neoplasm of anterior wall of bladder
|
C673 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 56.60%
|
25.64%
|
7.45%
|
3.52%
|
1.95%
|
1.58%
|
0.95%
|
0.75%
|
0.38%
|
0.43%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C67.3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,595
|
1,597
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,570
|
2,412
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,523
|
1,538
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,521
|
1,525
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,393
|
1,393
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,390
|
6,052
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,341
|
31,513
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
1,092
|
1,246
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
970
|
3,783
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
938
|
1,991
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
929
|
6,415
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
710
|
1,050
|
|
52235
|
CYSTOSCOPY AND TREATMENT |
682
|
682
|
|
J7120
|
RINGERS LACTATE INFUSION |
659
|
832
|
|
51720
|
TREATMENT OF BLADDER LESION |
656
|
656
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
647
|
57,348
|
|
80048
|
METABOLIC PANEL TOTAL CA |
608
|
608
|
|
77386
|
NTSTY MODUL RAD TX DLVR CPLX |
595
|
595
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
580
|
1,903
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
502
|
1,023
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C67.3 related to the following DRG Codes:
656-658
686-688
|
